PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.85%
Some net income increase while MRVL is negative at -106.38%. John Neff would see a short-term edge over the struggling competitor.
-0.82%
Negative yoy D&A while MRVL is 3.02%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
136.36%
Well above MRVL's 100.31% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
45.24%
SBC growth well above MRVL's 12.25%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-179.62%
Negative yoy working capital usage while MRVL is 136.67%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-672.73%
AR is negative yoy while MRVL is 721.81%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-44.44%
Both reduce yoy inventory, with MRVL at -17.36%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
2200.00%
AP growth well above MRVL's 87.79%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-204.79%
Negative yoy usage while MRVL is 80.73%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
97.80%
Well above MRVL's 102.72%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-12.94%
Negative yoy CFO while MRVL is 214.53%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-45.28%
Both yoy lines negative, with MRVL at -79.34%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Both yoy lines negative, with MRVL at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-18.33%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
26.02%
Liquidation growth of 26.02% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
91.81%
Less 'other investing' outflow yoy vs. MRVL's 310.44%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-11.35%
Both yoy lines negative, with MRVL at -103.54%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-10.00%
We cut debt repayment yoy while MRVL is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
71.93%
Issuance growth of 71.93% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-566.67%
We cut yoy buybacks while MRVL is 91.60%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.